IMDX
Insight Molecular Diagnostics Inc.Company with tickers: IMDX
CIK
1642380
CUSIP
68235C206
Shares Outstanding
32,290,167
13F Activity (30d)
33 filings
33 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,138,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | $813,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Gross Profit | $1,325,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $8,124,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $2,924,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-6,799,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-6,671,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.26 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.26 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |